Drug

Culmerciclib clinical trials

studies test it: 18
open now: 9
in phase 3: 3
first study started: 2019

Keep track of what changes. Save the culmerciclib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

18 studies that test it; most in 2026 (7)

Studies that test culmerciclib, by start year
Year	Studies
2019	1
2021	3
2022	3
2023	1
2024	2
2025	1
2026	7

By phase

A phase 1/2 study counts in both.

Phase 1: 5
Phase 2: 11
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms: 7
Liposarcoma: 1

Who runs them

Industry 10 · Other 8

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (10) · Sun Yat-sen University (2) · Hebei Medical University Fourth Hospital (1) · Shengjing Hospital (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Fudan University (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · Peking University (1)

Often tested with

Tested in the same studies.

Fulvestrant (3) · Letrozole (2) · Trastuzumab (2) · Pertuzumab (2) · Anastrozole (1) · Tamoxifen (1) · TQB2440 (1) · Anlotinib (1)

Studies

Open first, then newest update. How each study uses culmerciclib is read from its arms, and is right about nine times in ten.

Testing it · 18

Given in every arm · 2 — culmerciclib is usual care beside what is tested

Codes

What other systems call culmerciclib · ClinicalTrials.gg INT018721

UNII (FDA) ZU5GL4E4WHCULMERCICLIBOne source FDA
NCI Thesaurus C203166CulmerciclibOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	ZU5GL4E4WH	CULMERCICLIB	One source FDA
NCI Thesaurus	C203166	Culmerciclib	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.